Regencell Bioscience Holdings Cash from Financing (TTM) Trends

Regencell Bioscience Holdings Ltd. (RGC)

8.40 -0.16 (-1.87%) USD | NASDAQ | Jun 25, 09:31

Cash from Financing (TTM) Chart

View Cash from Financing (TTM) for RGC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Financing (TTM) Chart

Start Trial

Historical Cash from Financing (TTM) Data

View and export this data back to . Start Trial.

Date	Value

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

View Cash from Financing (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cash from Financing (TTM) Benchmarks

View Cash from Financing (TTM) Benchmarks

Start Trial

Sino Biopharmaceutical Ltd.	619.54M
HUTCHMED (China) Ltd.	7.858M
Regent Pacific Group Ltd.	4.346M
SSY Group Ltd.	-37.66M
Beijing Tong Ren Tang Chinese Medicine Co., Ltd.	-48.86M